BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21623166)

  • 21. ERK5 signalling in prostate cancer promotes an invasive phenotype.
    Ramsay AK; McCracken SR; Soofi M; Fleming J; Yu AX; Ahmad I; Morland R; Machesky L; Nixon C; Edwards DR; Nuttall RK; Seywright M; Marquez R; Keller E; Leung HY
    Br J Cancer; 2011 Feb; 104(4):664-72. PubMed ID: 21266977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of NDRG2 and NDRG3 in prostate cancer patients undergoing radical prostatectomy.
    Ren GF; Tang L; Yang AQ; Jiang WW; Huang YM
    Histol Histopathol; 2014 Apr; 29(4):535-42. PubMed ID: 24222185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia.
    Zhong W; Peng J; He H; Wu D; Han Z; Bi X; Dai Q
    Clin Invest Med; 2008; 31(1):E8-E15. PubMed ID: 18312749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo.
    Xiao Y; Yuan Y; Zhang Y; Li J; Liu Z; Zhang X; Sheng Z; Xu T; Wang X
    Clin Transl Oncol; 2015 Jun; 17(6):431-7. PubMed ID: 25387568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. hnRNPM, a potential mediator of YY1 in promoting the epithelial-mesenchymal transition of prostate cancer cells.
    Yang T; An Z; Zhang C; Wang Z; Wang X; Liu Y; Du E; Liu R; Zhang Z; Xu Y
    Prostate; 2019 Aug; 79(11):1199-1210. PubMed ID: 31251827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression Levels of IL-17A, IL-17F, IL-17RA, and IL-17RC in Prostate Cancer with Taking into Account the Histological Grade according to Gleason Scale in Comparison to Benign Prostatic Hyperplasia: In Search of New Therapeutic Options.
    Janiczek M; Szylberg Ł; Antosik P; Kasperska A; Marszałek A
    J Immunol Res; 2020; 2020():4910595. PubMed ID: 32537467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression.
    Ferronika P; Triningsih FX; Ghozali A; Moeljono A; Rahmayanti S; Shadrina AN; Naim AE; Wudexi I; Arnurisa AM; Nanwani ST; Harijadi A
    Asian Pac J Cancer Prev; 2012; 13(5):1943-8. PubMed ID: 22901151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].
    Zhou WQ; Sun YH; Yin HL; Zhang ZY; Ge JP; Cheng W; Ma HQ; Wei W; Zhou SG; Ma HH; Gao JP
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):685-9. PubMed ID: 17918704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines.
    Singh S; Singh R; Singh UP; Rai SN; Novakovic KR; Chung LW; Didier PJ; Grizzle WE; Lillard JW
    Int J Cancer; 2009 Nov; 125(10):2288-95. PubMed ID: 19610059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
    Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.
    Cordon-Cardo C; Koff A; Drobnjak M; Capodieci P; Osman I; Millard SS; Gaudin PB; Fazzari M; Zhang ZF; Massague J; Scher HI
    J Natl Cancer Inst; 1998 Sep; 90(17):1284-91. PubMed ID: 9731735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenovirus-mediated NDRG2 inhibits the proliferation of human renal cell carcinoma cell line OS-RC-2 in vitro.
    Wu Z; Liao H; Su J; Yang L; Chi Z; OuYang X
    Cell Biochem Biophys; 2014 Sep; 70(1):593-600. PubMed ID: 24839115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro and in vivo inhibitory effect of Ad-ING4 gene on proliferation of human prostate cancer PC-3 cells].
    Yang HC; Sheng WH; Xie YF; Miao JC; Wei WX; Yang JC
    Ai Zheng; 2009 Nov; 28(11):1149-57. PubMed ID: 19895734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of NDRG2 overexpression, X-ray radiation and docetaxel enhances apoptosis and inhibits invasiveness properties of LNCaP cells.
    Alizadeh Zarei M; Rafiei Dehbidi G; Takhshid MA
    Urol Oncol; 2020 Nov; 38(11):849.e1-849.e9. PubMed ID: 32665121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and significance of PCNA and p27 in benign prostate hypertrophy and prostate carcinoma].
    Lai JS; Xia Q; Zhang XB; Zhao GP; Xu SL; Zheng DS
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):476-8. PubMed ID: 15555337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenovirus siMDM2 and NDRG2 Gene Therapy Inhibits Cell Proliferation and Induces Apoptosis of Squamous Cell Carcinoma.
    Wang S; Chen N; Dong N; Lu L; Liu L; Zhang L
    Cell Biochem Biophys; 2015 Nov; 73(2):513-518. PubMed ID: 27352346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of drs mRNA in human prostate carcinomas.
    Kim CJ; Shimakage M; Kushima R; Mukaisho K; Shinka T; Okada Y; Inoue H
    Hum Pathol; 2003 Jul; 34(7):654-7. PubMed ID: 12874760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. βKlotho inhibits androgen/androgen receptor‑associated epithelial‑mesenchymal transition in prostate cancer through inactivation of ERK1/2 signaling.
    Liu Z; Zhang H; Ding S; Qi S; Liu S; Sun D; Dong W; Yin L; Li M; Zhao X; Lu J
    Oncol Rep; 2018 Jul; 40(1):217-225. PubMed ID: 29749458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.